Page 29 - Sartorius News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RoosterBio Partners with Sartorius to Advance Cell and Gene Therapy Manufacturing RoosterBio's innovative hMSCs and bioprocess media systems, coupled with Sartorius's scalable closed system bioreactor, downstream processing, and analytics, offers end-to-end hMSC manufacturing solutions for the field of regenerative medicine. FREDERICK, Md., Jan. 14, 2021 (GLOBE NEWSWIRE) -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media and hMSC bioprocess systems, today announces the signing of a strategic collaboration with Sar...

Editorial Article: The quest for precision medicine: Decoding cancer pathogenesis and overcoming drug resistance Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies 08 Jan 2021  Dr. Komal Kumar Javarappa Blood cancers such as multiple myeloma and acute myeloid leukemia (AML) are relatively rare but often result in worse prognoses compared to many other cancer types. In the past few decades, our understanding has vastly improved and extensive research has increased ...

Posted January 6th, 2021 for Sartorius Göttingen, January 6, 2021 Proposed transaction builds on both companies’ strategic R&D partnership Strengthens Sartorius position in downstream bioprocessing The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained. Novasep’s division expects to generate sales revenue of approx...